Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has launched Ziprasidone Mesylate for Injection, 20 mg (base)/ml Single-dose Vials, the therapeutic generic equivalent of Geodon (ziprasidone mesylate) Injection, 20 mg/ml, approved by the U.S. Food and Drug Administration (USFDA). According to IQVIA Health, the Geodon brand had U.S. sales of approximately $21.8 million MAT for the most recent twelve months ending in January 2020.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.